DeHeng Assisted Zhongheng Group and NIIG United Investment Group Co., Ltd. in Establishing a Joint Venture with Fosun Pharma to Expand Overseas Pharmaceutical Business

2025-03-21

Recently, Fosun Pharmaceutical (Nanning) Co., Ltd. was established in Nanning, Guangxi, as a joint venture between Shanghai Fosun Pharmaceutical Industry Development Co., Ltd., a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma,” stock code: 600196), and Zhongheng Yixing Science and Technology Investment Co., Ltd., a subsidiary of Guangxi Wuzhou Zhongheng Group Co., Ltd. (“Zhongheng Group,” stock code: 600252), and NIIG United Investment Group Co., Ltd. With a registered capital of RMB 100 million, the joint venture will focus on expanding the pharmaceutical business in ASEAN countries.

As the special legal advisor for the investors NIIG United Investment Group Co., Ltd. and Zhongheng Group in this project, the DeHeng team, led by partner Wang Yuwei, with primary support from partners Hong Xiaolong and lawyer Liang Chen, worked closely with the clients and provided comprehensive, professional, and efficient legal due diligence services for the joint venture project, including providing legal advice on the establishment of the joint venture, earning unanimous praise from the clients.